Seeing Is Believing
Currently out of the existing stock ratings of Andrew Fein, 17 are a HOLD (4.27%), 381 are a BUY (95.73%).
Analyst Andrew Fein works with a stock forecast success ratio of 33.17% fulfilled within 137.4 days on average. Previously, Andrew Fein worked at HCWAINWRIGHT.
Andrew Fein’s has documented 791 price targets and ratings displayed on 57 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 25-Apr-2024.
Analyst best performing recommendations are on SVRA (SAVARA).
The best stock recommendation documented was for SVRA (SAVARA) at 6/12/2019. The price target of $6 was fulfilled within 1 day with a profit of $4.57 (43.24%) receiving and performance score of 432.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.29 (49.61%)
29
1 months 6 days ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$13.29 (79.53%)
40
1 months 18 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$22.29 (133.39%)
40
2 months 3 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$16.29 (97.49%)
33
2 months 3 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$19.29 (115.44%)
2 months 3 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Andrew Fein is most bullish on?
Which stock is Andrew Fein is most reserved on?
What Year was the first public recommendation made by Andrew Fein?